SION
Sionna Therapeutics, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 5 ▼ 1 insider sell $347.0K at $33.86
- Apr 14 to Apr 18 ▼ 5 days of insider sells: $50.8M by 2 insiders, avg $44.91
- May 7 to May 11 ▼ 3 days of insider sells: $26.7M by 2 insiders, avg $45.62
- May 12 Sionna reported Q1 2026 GAAP EPS of -$0.60, a 3.2% beat vs consensus…
- May 27 ▼ 2 insiders sell $9.0K at $44.49
- May 29 ▼ OrbiMed Advisors LLC filed a Form 144 on May 29, 2026, signaling int…
- Jun 30 to Jul 7 ▼ 3 days of insider sells: $18.7M by 3 insiders, avg $45.19
- Aug 10 ▼ Sionna Therapeutics announced that its Phase 2a PreciSION CF trial o…
- Aug 11 ▼ 2 downgrades
- Sep 10 Trial readout: Results Pending: SION-719 (Phase 2), Completed 77d ago
- Sep 17 ▼ 1 insider sell $21.8M at $6.33
- Sep 21 ▼ RA Capital Management has filed Amendment No. 2 to its Schedule 13D,…
Signal stack
Where each data set points today.
- InsidersBEARISH
4 insiders sold $118.5M.
- InstitutionsBULLISH
Q3 2026: 23 added (0 new), 13 trimmed or exited.
- AnalystsMIXED
6 of 17 rate it Buy or better.
- Short sellersSTEADY
Short interest +14.6% to 4.21M shares. 4.1 days to cover, ≈9.3% of shares.
- TrendDOWNTREND
32% below its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| BlackRock, Inc. | ADD | $14.1M |
| Aberdeen Group plc | DOUBLED | $7.1M |
| Walleye Capital LLC | DOUBLED | $2.4M |
| MARSHALL WACE, LLP | DOUBLED | $2.3M |
| STATE STREET CORP | TRIM | $2.0M |
| MORGAN STANLEY | DOUBLED | $1.6M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | ADD | $1.6M |
| BNP PARIBAS FINANCIAL MARKETS | DOUBLED | $1.4M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
17 analysts| Date | Firm | Rating |
|---|---|---|
| Sep 15, 2026 | Wedbush MAINTAIN | Neutral |
| Aug 11, 2026 | Guggenheim DOWNGRADE | Neutral |
| Aug 11, 2026 | Wedbush DOWNGRADE | Neutral |
| Aug 10, 2026 | BTIG DOWNGRADE | Neutral |
| Aug 7, 2026 | Guggenheim MAINTAIN | Buy |
| May 26, 2026 | Citizens REITERATE | Market Outperform |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Cloonan Michael President & CEO Sep 17, 2026 | TO ISSUER | 436,100 sh |
Fitzpatrick Jennifer CLO and Head of Program Mgmt. Sep 17, 2026 | AWARD | 28,133 sh |
Fitzpatrick Jennifer CLO and Head of Program Mgmt. Sep 17, 2026 | AWARD | 28,132 sh |
Fitzpatrick Jennifer CLO and Head of Program Mgmt. Sep 17, 2026 | TO ISSUER | 103,140 sh |
McKee Charlotte CMO and Head of R&D Sep 17, 2026 | AWARD | 50,000 sh |
Ridloff Elena CFO and CBO Sep 17, 2026 | AWARD | 165,440 sh |
Ridloff Elena CFO and CBO Sep 17, 2026 | TO ISSUER | 165,440 sh |
McKee Charlotte CMO and Head of R&D Sep 17, 2026 | AWARD | 155,700 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | -$0.52 | -$0.72–-$0.41 | -19.1% | $0.00 |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 30, 2026SecBot reports
20 filings · 2 press releases · 0 bullish · 9 bearish · 1 mixed · 10 neutral- NEUTRAL PRESS-RELEASENov 10, 2026
Sionna reported a Q3 2026 net loss of $32.4M ($0.72 per share), wider than the $20.3M loss a year…
The Phase 2 AscenSION CF trial initiation in Q1 2027 is the key near-term catalyst. Monitor enrollment and any early efficacy signals (sweat chloride reduction) from the 28-day study. The cash…
- NEUTRAL SC 13GNov 9, 2026
Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC disclosed a 5.8% passive stake in…
Monitor for any future amendments that could indicate a shift from passive to active intent, or for additional 13G filings by other institutional holders that would increase the known institutional…
- NEUTRAL INST-CLUSTERNov 3, 2026
Three institutional investors added to their SION positions in Q3 2026, but the aggregate net…
The cluster is too small in dollar terms (<$350K aggregate) to signal a strong institutional thesis. Monitor upcoming 13F filings for larger funds or a reversal in the insider-institutional…
- MIXED INST-CLUSTERSep 22, 2026
Institutional activity in SION during Q2 2026 was mixed: 25 buyers added $35.7M in net new…
The mixed institutional cluster, heavy passive buying offset by active manager trimming, suggests no strong consensus thesis. Monitor upcoming 13F filings for Q3 to see if the buying trend…
All SION filing & press-release reports (22)
- PRESS-RELEASE reportNov 10, 2026
- SC 13G reportNov 9, 2026
- INST-CLUSTER reportNov 3, 2026
- INST-CLUSTER reportSep 22, 2026
- SC 13D/A reportSep 21, 2026
- 144 reportSep 17, 2026
- 8-K reportAug 10, 2026
- 8-K reportAug 6, 2026
- CLUSTER reportJul 9, 2026
- CLUSTER reportJul 9, 2026
- CLUSTER reportJul 7, 2026
- CLUSTER reportJul 2, 2026
- INST-CLUSTER reportJun 11, 2026
- CLUSTER reportMay 29, 2026
- 144 reportMay 29, 2026
- 8-K reportMay 12, 2026
- PRESS-RELEASE reportMay 12, 2026
- CLUSTER reportMay 7, 2026
- PRESS-RELEASE reportApr 27, 2026
- CLUSTER reportApr 16, 2026
- CLUSTER reportApr 15, 2026
- PRESS-RELEASE reportMar 2, 2026